title: RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis.
abstract: Previous studies have analyzed transfer of RNA-encoded tumor-associated antigens (TAAs) into immature dendritic cells (DCs) because of their exceptional ability to internalize antigens. Concerns have been raised regarding the use of immature DCs in clinical studies because of their capacity to tolerize T cells. Therefore, we focused on optimizing RNA transfer into mature DCs using the method of electroporation and obtained high protein expression in 90% of mature DCs. Particular emphasis was placed on quantifying RNA transfer. Reconstitution of peptide-MHC (pMHC) ligands on RNA-pulsed DCs was measured with the help of effector-memory cytotoxic T lymphocytes (CTLs) specific for the melanoma-associated antigens tyrosinase and mutated cyclin-dependent kinase 4. In contrast to single-species RNA, transfer of native tumor-derived RNA or amplified tumor RNA into DCs resulted in very low or no capacity to reactivate these CTLs. A correlation was found between TAA message levels in tumor-derived RNA and pMHC ligand reconstitution on DCs. These results demonstrate that even TAAs with highly immunogenic mutated epitopes are not necessarily transferred when tumor-derived RNA is transfected into the DCs, thereby resulting in a lack of DC capacity to reactivate some preexisting effector-memory CTLs.
authors.affiliation: Institute of Molecular Immunology, GSF National Research Center for Environment and Health, Munich, Germany. miran.javorovic@gsf.de
authors.forename: Miran
authors.initials: M
authors.lastname: Javorovic
authors.forename: Heike
authors.initials: H
authors.lastname: Pohla
authors.forename: Bernhard
authors.initials: B
authors.lastname: Frankenberger
authors.forename: Thomas
authors.initials: T
authors.lastname: Wölfel
authors.forename: Dolores J
authors.initials: DJ
authors.lastname: Schendel
mesh_terms: D045744:Cell Line, Tumor; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology*; D018274:Electroporation / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008213:Lymphocyte Activation; D008545:Melanoma / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D010641:Phenotype; D012313:RNA / Q000235:genetics* / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014162:Transfection / Q000379:methods*
chemical_list: D012313:RNA